Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma

被引:0
|
作者
Takamichi Ishii
Takashi Ito
Shinji Sumiyoshi
Satoshi Ogiso
Ken Fukumitsu
Satoru Seo
Kojiro Taura
Shinji Uemoto
机构
[1] Kyoto University,Department of Surgery, Graduate School of Medicine
[2] Kyoto University Hospital,Department of Diagnostic Pathology
关键词
cHCC-CC; CHC; Recurrence;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA: AN INDICATION FOR LIVER TRANSPLANTATION?
    Schaefer, I. -M.
    Reinecke, J. A.
    Goralczyk, A.
    Schultze, F. C.
    Amanzada, A.
    Schweyer, S.
    Lorf, T.
    Obed, A.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 39 - 39
  • [42] EXPRESSION OF ABH AND LEWIS BLOOD-GROUP ANTIGENS IN COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA - POSSIBLE EVIDENCE FOR THE HEPATOCELLULAR ORIGIN OF COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA
    OKADA, Y
    JINNO, K
    MORIWAKI, S
    MORICHIKA, S
    TORIGOE, SI
    ARIMA, T
    NAGASHIMA, H
    KOPROWSKI, H
    CANCER, 1987, 60 (03) : 345 - 352
  • [43] Nodal recurrence mapping and clinical target volumes after resection of intrahepatic cholangiocarcinoma or combined hepatocellular-cholangiocarcinoma
    Yang, Zhuanbo
    Wang, Liming
    Zhai, Yirui
    Zhao, Jianjun
    Ye, Feng
    Wang, Shulian
    Jiang, Liming
    Song, Yan
    Sun, Yongkun
    Zhu, Ji
    Tang, Yuan
    Liu, Yueping
    Song, Yongwen
    Fang, Hui
    Li, Ning
    Qi, Shunan
    Lu, Ningning
    Li, Ye-Xiong
    Zhao, Hong
    Chen, Bo
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 45
  • [44] Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers
    Wakizaka, Kazuki
    Yokoo, Hideki
    Kamiyama, Toshiya
    Ohira, Masafumi
    Kato, Koichi
    Fujii, Yuki
    Sugiyama, Ko
    Okada, Naoki
    Ohata, Takanori
    Nagatsu, Akihisa
    Shimada, Shingo
    Orimo, Tatsuya
    Kamachi, Hirofumi
    Taketomi, Akinobu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (06) : 1074 - 1080
  • [45] Is nestin a diagnostic marker for combined hepatocellular-cholangiocarcinoma?
    Sasaki, M.
    Sato, Y.
    Nakanuma, Y.
    HISTOPATHOLOGY, 2022, 80 (05) : 859 - 868
  • [46] Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection
    Chi, Chen-Ta
    Chau, Gar-Yang
    Lee, Rheun-Chuan
    Chen, Yen-Ying
    Lei, Hao-Jan
    Hou, Ming-Chih
    Chao, Yee
    Huang, Yi-Hsiang
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 (01) : 125 - 133
  • [47] A HISTOCHEMICAL-STUDY ON COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA
    UEKUSA, T
    MASTUMOTO, T
    ABE, H
    FUKUDA, Y
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 1985, 18 (06) : 673 - 673
  • [48] Editorial for "Combined Hepatocellular-Cholangiocarcinoma: MRI Features and Prognosis According to Risk Factors for Hepatocellular Carcinoma"
    Xu, Xiaopan
    Liu, Yang
    Lu, Hongbing
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2021, 53 (06) : 1813 - 1814
  • [49] Epigenetic regulation of combined hepatocellular-cholangiocarcinoma subtypes
    Schachtschneider, Kyle M.
    Lokken, Ryan Peter
    Huang, Yu-Hui
    Guzman, Grace
    Schook, Lawrence B.
    Gaba, Ron C.
    CANCER RESEARCH, 2019, 79 (13)
  • [50] COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA - A HISTOLOGIC AND IMMMUNOHISTOCHEMICAL STUDY
    GOODMAN, ZD
    ISHAK, KG
    LANGLOSS, JM
    SESTERHENN, IA
    RABIN, L
    CANCER, 1985, 55 (01) : 124 - 135